Valuation: Optiscan Imaging Limited

Market Cap 162M 114M 102M 93.8M 84.99M 159M 10.81B 1.12B 449M 5.69B 427M 418M 17.94B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 149M 105M 93.78M 86.26M 78.16M 146M 9.94B 1.03B 413M 5.23B 393M 385M 16.49B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.64%
Yield 2025 *
-
Yield 2026 -
1 day+3.33%
1 week-3.12%
1 month+14.81%
3 months+6.90%
6 months+40.91%
Current year+55.00%
1 week 0.14
Extreme 0.14
0.16
1 month 0.14
Extreme 0.14
0.2
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.26
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 12/12/2021
Director of Finance/CFO - 31/03/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 09/02/2021
Chairman - 18/04/2021
Director/Board Member - 05/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Exercice

Chief Executive Officer

-595,981 0.0571%
14/09/26 Expiration

Chief Executive Officer

-595,981 0.0571%
14/09/26 Exercice

Chief Executive Officer

595,981 0.0571%
Change 5-day change 1-year change 3-year change Capi.($)
+3.33%-3.12%+29.17%+93.75% 114M
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-.--%+2.46%-11.69%-7.41% 53.31B
-2.57%+3.30%+11.59%+44.40% 53.03B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.47%+1.04%+19.48%+69.17% 49.3B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.46%-0.59%+4.16%+48.07% 88.41B
Weighted average by Cap. -2.10%+0.15%+4.04%+44.66%

Financials

2025 2026
Net sales 3.72M 2.62M 2.35M 2.16M 1.96M 3.66M 249M 25.74M 10.33M 131M 9.83M 9.62M 413M 3.61M 2.54M 2.28M 2.09M 1.9M 3.55M 241M 24.97M 10.03M 127M 9.54M 9.34M 400M
Net income -6.31M -4.44M -3.98M -3.66M -3.31M -6.2M -422M -43.63M -17.51M -222M -16.67M -16.31M -699M -6.99M -4.91M -4.4M -4.05M -3.67M -6.86M -467M -48.28M -19.38M -245M -18.45M -18.05M -774M
Net Debt -3.07M -2.16M -1.93M -1.78M -1.61M -3.01M -205M -21.22M -8.52M -108M -8.11M -7.94M -340M -13.01M -9.15M -8.2M -7.54M -6.83M -12.77M -869M -89.9M -36.09M -457M -34.34M -33.61M -1.44B
Projected Income Statement - Annual - Optiscan Imaging Limited
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
30/10/26 A$0.1550 +3.33% 200,756
29/10/26 A$0.1500 +3.45% 46,395
28/10/26 A$0.1450 +3.57% 22,023
27/10/26 A$0.1400 -9.68% 57,321
26/10/26 A$0.1550 -3.13% 209,042